- Nachrichtendetail
-
16.05.2024 12:49:33 - dpa-AFX: *ARVINAS, PFIZER ANNOUNCE UPDATED CLINICAL DATA FROM PHASE 1B TRIAL OF VEPDEGESTRANT WITH PALBOCICLIB
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Pfizer | 852009 | NYSE | 28,840 | 06.06.24 20:05:59 | -0,710 | -2,40% | 28,840 | 28,850 | 29,560 | 29,550 |
